Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heterogeneity of Striatal Dopamine Function in Schizophrenia: Meta-analysis of Variance
Stefan Brugger, Ilinca Angelescu, Anissa Abi‐Dargham, et al.
Biological Psychiatry (2019) Vol. 87, Iss. 3, pp. 215-224
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

Dopamine and glutamate in schizophrenia: biology, symptoms and treatment
Robert A. McCutcheon, John H. Krystal, Oliver Howes
World Psychiatry (2020) Vol. 19, Iss. 1, pp. 15-33
Open Access | Times Cited: 457
Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia
Jean Claude Martel, Silvia Gatti McArthur
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 191
The effects of social isolation stress and discrimination on mental health
Lasse Brandt, Shuyan Liu, Christine Heim, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 164
The clinical significance of duration of untreated psychosis: an umbrella review and random‐effects meta‐analysis
Oliver Howes, Thomas Whitehurst, Ekaterina Shatalina, et al.
World Psychiatry (2021) Vol. 20, Iss. 1, pp. 75-95
Open Access | Times Cited: 160
Integrating the Neurodevelopmental and Dopamine Hypotheses of Schizophrenia and the Role of Cortical Excitation-Inhibition Balance
Oliver Howes, Ekaterina Shatalina
Biological Psychiatry (2022) Vol. 92, Iss. 6, pp. 501-513
Open Access | Times Cited: 159
A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia
Christoph U. Correll, Ofer Agid, Benedicto Crespo‐Facorro, et al.
CNS Drugs (2022) Vol. 36, Iss. 7, pp. 659-679
Open Access | Times Cited: 97
Quantitative evidence synthesis: a practical guide on meta-analysis, meta-regression, and publication bias tests for environmental sciences
Shinichi Nakagawa, Yefeng Yang, Erin L. Macartney, et al.
Environmental Evidence (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 77
Schizophrenia: from neurochemistry to circuits, symptoms and treatments
Oliver Howes, Bernard R Bukala, Katherine Beck
Nature Reviews Neurology (2023) Vol. 20, Iss. 1, pp. 22-35
Closed Access | Times Cited: 54
New Drug Treatments for Schizophrenia: A Review of Approaches to Target Circuit Dysfunction
Oliver Howes, Eleanor Dawkins, Maria Lobo, et al.
Biological Psychiatry (2024) Vol. 96, Iss. 8, pp. 638-650
Open Access | Times Cited: 18
Revisiting and expanding the meta‐analysis of variation: The log coefficient of variation ratio
Alistair M. Senior, Wolfgang Viechtbauer, Shinichi Nakagawa
Research Synthesis Methods (2020) Vol. 11, Iss. 4, pp. 553-567
Open Access | Times Cited: 74
New and emerging treatments for schizophrenia: a narrative review of their pharmacology, efficacy and side effect profile relative to established antipsychotics
Maria Lobo, Thomas Whitehurst, Stephen Kaar, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 132, pp. 324-361
Open Access | Times Cited: 57
Compositional and Functional Alterations in Intestinal Microbiota in Patients with Psychosis or Schizophrenia: A Systematic Review and Meta-analysis
Nuala Murray, Sukainah Al Khalaf, Thomaz F. S. Bastiaanssen, et al.
Schizophrenia Bulletin (2023) Vol. 49, Iss. 5, pp. 1239-1255
Open Access | Times Cited: 26
Neurostructural subgroup in 4291 individuals with schizophrenia identified using the subtype and stage inference algorithm
Yuchao Jiang, Cheng Luo, Jijun Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Striatal Dopamine and Reward Prediction Error Signaling in Unmedicated Schizophrenia Patients
Teresa Katthagen, Jakob Kaminski, Andreas Heinz, et al.
Schizophrenia Bulletin (2020) Vol. 46, Iss. 6, pp. 1535-1546
Open Access | Times Cited: 61
Integrating the Roles of Midbrain Dopamine Circuits in Behavior and Neuropsychiatric Disease
Allen P. F. Chen, Lu Chen, Thomas A. Kim, et al.
Biomedicines (2021) Vol. 9, Iss. 6, pp. 647-647
Open Access | Times Cited: 43
Cerebral blood flow in schizophrenia: A systematic review and meta-analysis of MRI-based studies
Olivier Percie du Sert, Joshua Unrau, Claudine Gauthier, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 121, pp. 110669-110669
Closed Access | Times Cited: 29
How changes in dopamine D2 receptor levels alter striatal circuit function and motivation
Eleanor H. Simpson, Eduardo F. Gallo, Peter D. Balsam, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 436-444
Open Access | Times Cited: 39
Heterogeneity in response to repeated intranasal oxytocin in schizophrenia and autism spectrum disorders: A meta‐analysis of variance
Daniel Martins, Maria Paduraru, Yannis Paloyelis
British Journal of Pharmacology (2021) Vol. 179, Iss. 8, pp. 1525-1543
Open Access | Times Cited: 36
Dopamine in major depressive disorder: A systematic review and meta-analysis of in vivo imaging studies
Yuya Mizuno, Hulegar A. Abhishekh, Bhagyashree Bhaskar Bhat, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 11, pp. 1058-1069
Open Access | Times Cited: 16
Decreased striatal adenosine A2A-dopamine D2 receptor heteromerization in schizophrenia
Marta Valle-León, Luís F. Callado, Ester Aso, et al.
Neuropsychopharmacology (2020) Vol. 46, Iss. 3, pp. 665-672
Open Access | Times Cited: 36
The substantia nigra in the pathology of schizophrenia: A review on post-mortem and molecular imaging findings
Carmen F.M. van Hooijdonk, Marieke van der Pluijm, Iris Bosch, et al.
European Neuropsychopharmacology (2023) Vol. 68, pp. 57-77
Open Access | Times Cited: 13
Cognitive impairment in schizophrenia is associated with prefrontal–striatal functional hypoconnectivity and striatal dopaminergic abnormalities
Kai‐Chun Yang, Bang‐Hung Yang, Mu‐N Liu, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 6, pp. 515-525
Closed Access | Times Cited: 4
Neuroimaging stratification reveals the striatal vulnerability to stress as a risk for schizophrenia
Xiaoqian Ma, Nana Feng, Lena Palaniyappan, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access
Correcting for Differences in Measurement Unreliability in Meta-Analysis of Variances
Katrin Jansen, Steffen Nestler
Multivariate Behavioral Research (2025), pp. 1-20
Open Access
Molecular imaging of schizophrenia: Neurochemical findings in a heterogeneous and evolving disorder
Paul Cumming, Anissa Abi‐Dargham, Gerhard Gründer
Behavioural Brain Research (2020) Vol. 398, pp. 113004-113004
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top